Leaders of the Massachusetts General Hospital Interdisciplinary Brain Center and Neuroscience Institute shared their progress toward understanding, treating and preventing brain disorders at the 12th annual Phillips Society luncheon.
Peter L. Slavin, MD, Mass General president, welcomed the 236 guests to the Sept. 13 event and thanked Phillips Society members for “helping us transform the future of medicine so the medicine for our children and grandchildren will be even better than it is today.” The Phillips Society represents those who include Mass General in their estate plan through a will or other planned gift, and those who establish an endowed fund.
Merit Cudkowicz, MD, MSc, chief of the Department of Neurology, spoke about emerging tools in imaging and genetics that may reveal new treatments for disorders of the brain, before introducing featured speakers, Jonathan Rosand, MD, MSc, chief of the Division of Neurocritical Care and Emergency Neurology, and Steven Arnold, MD, of the Department of Neurology.
“We are living in a golden age of health,” said Arnold. “We’re living longer, healthier and more productive lives. But such longevity increases the risk of neurodegenerative diseases.”
Rosand said that exercise of the body and brain, proper sleep and stress control may combat the onset of neurodegenerative diseases such as Alzheimer’s or Parkinson’s. He said he envisions neurological tests will become standard primary care practice, much like cholesterol and lipid tests to predict heart disease are today.
“Not only do we work with individuals who are tops in their respective fields but we really work well together across disciplines,” Rosand said. “There is something in the culture at Mass General that allows us to break down silos.”